Jamie Hartford is editor-in-chief of MD+DI and director of content for medtech brands in UBM's Advanced Manufacturing Group, where she oversees content creation for the MD&M and BIOMEDevice conferences. Reach her at firstname.lastname@example.org.
The new GOP tax law gives companies more flexibility when it comes to capital allocation, Johnson & Johnson's CFO says. Could that lead to an uptick in mergers and acquisitions among medical device and diagnostics companies?
Experts offer their predictions for what's in store for the medical device and diagnostics industry over the next 12 months.
MD+DI’s editors chose Abbott as the 2017 Medtech Company of the Year, but our readers had a different opinion.
These companies have risen above the rest in 2017. Which one do you think deserves to wear the crown?
Have a burning question about how to start out in medtech or advance your career in the industry? Submit it here for a chance to receive a free conference pass to BIOMEDevice San Jose.
If you have an idea for a medtech innovation but are having a hard time getting investors or upper management to hear you out, follow these tips.
Medtech career experts offer advice on landing a job, advancing your career, and increasing your earning power.
MD&M Minneapolis is the place to see the latest and greatest offerings from medtech industry suppliers and service providers, and you'll definitely want to check out these five products at the show.
BD still plans to enter the estimated $1 billion market for insulin patch pumps for patients with type 2 diabetes, but its first product won't launch as soon as the company initially anticipated.
Best-selling author, cardiologist, and digital health researcher Eric Topol hopes artificial intelligence can help bring empathy back to healthcare.
MD+DI is looking for professionals working in the medical device and diagnostics industry to contribute articles on a variety of topics—and you'll get paid for it.
The single-use biometric patch has a seven-day battery life, measures heart rate, respiratory rate, and body temperature, and costs around $3.
Machine learning might be our only hope to curb out of control healthcare costs, according to a top venture capitalist and Medtronic CEO Omar Ishrak.